Last updated: April 23, 2026
What is Ozobax?
Ozobax is the brand name for baclofen (skeletal muscle relaxant). In most markets where Ozobax is marketed, the drug substance and finished-dose supply chain is structured around:
- API manufacturers producing baclofen (active pharmaceutical ingredient)
- Finished-dose manufacturers producing tablets/capsules for the local brand owner
- Brand registrants/marketing authorization holders (MAHs) coordinating local regulatory filings, import logistics, and pharmacovigilance
Which suppliers make and sell into Ozobax supply?
No supplier-level information for Ozobax (specific API site, specific finished-dose manufacturer, or named contract manufacturers) is available in the provided prompt.
Because the request asks for “Suppliers for the pharmaceutical drug: OZOBAX,” the answer must name:
- API supplier(s) for baclofen used in Ozobax
- Finished dosage manufacturer(s) for Ozobax
- Local MAH/registrant(s) tied to Ozobax distribution
Those details depend on the country-specific product dossier (marketing authorization, label, and regulatory database entry). Without that jurisdictional product record, supplier names cannot be produced accurately.
How Ozobax supplier identification is determined (what the supply chain data must come from)
To identify Ozobax suppliers in a way that is actionable for procurement, licensing, or investment diligence, the supplier roster must be traced through the following evidence types:
1) Marketing authorization dossier (MAH + manufacturer(s))
Product registration entries typically list:
- Applicant/MAH
- Manufacturing site(s) for the finished product (and sometimes the release site)
- Manufacturer(s) of the API (or controlled by a “manufactured by” declaration)
2) Labeling and packaging
Outer carton and blister labels often show:
- Manufacturer name and address for the finished dose
- Product batch details and site identifiers
3) Drug master file (DMF) or API supplier reference
Where referenced in regulatory documents or filings, DMF holders link to:
- Baclofen API supplier site(s)
- Spec and control references
What can be stated from the available information
Only the active ingredient identification can be stated reliably:
- Ozobax contains baclofen (drug substance)
No supplier list for Ozobax can be stated without jurisdiction-specific product registration or labeling sources, which are not provided in the prompt.
Key Takeaways
- Ozobax is baclofen, a muscle relaxant.
- Supplier-level answers for Ozobax require country-specific registration or labeling evidence that is not included in the prompt.
- No named API supplier, finished-dose manufacturer, or MAH registrant can be provided accurately from the information available.
FAQs
1) Is Ozobax always baclofen across all markets?
Yes. Ozobax is a baclofen brand.
2) Can I infer Ozobax suppliers from the baclofen API supplier alone?
No. The API supplier and the finished-dose manufacturer are often different entities across markets.
3) Do Ozobax manufacturers change by country?
Yes. Product dossiers and manufacturing arrangements are typically jurisdiction-specific.
4) Where do supplier names for Ozobax come from in practice?
From local marketing authorization listings, product labels, and regulatory dossier documents.
5) What is the fastest way to get the supplier roster for diligence?
Use the Ozobax marketing authorization record for the target country and extract the listed API and finished-dose manufacturing sites plus the MAH.
References (APA)
[1] DailyMed. (n.d.). Baclofen (systemic) prescribing information. U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/
[2] European Medicines Agency. (n.d.). Baclofen assessment history and product information (where applicable). https://www.ema.europa.eu/
